Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 107

    1.

    Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.

    Peretti N, Marcil V, Drouin E, Levy E.

    Nutr Metab (Lond). 2005 May 3;2(1):11.PMID: 15869703 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Hypothesis: vitamin E complements polyunsaturated fatty acids in essential fatty acid deficiency in cystic fibrosis.

    Wood LG, Fitzgerald DA, Garg ML.

    J Am Coll Nutr. 2003 Aug;22(4):253-7. Review.PMID: 12897038 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cystic fibrosis: nutritional consequences and management.

    Dodge JA, Turck D.

    Best Pract Res Clin Gastroenterol. 2006;20(3):531-46. Review.PMID: 16782527 [PubMed - indexed for MEDLINE]Related articles

    4.

    Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis.

    Laiho KM, Gavin J, Murphy JL, Connett GJ, Wootton SA.

    Clin Nutr. 2004 Jun;23(3):347-53.PMID: 15158298 [PubMed - indexed for MEDLINE]Related articles

    5.

    Diagnosis and treatment of intestinal malabsorption in cystic fibrosis.

    Littlewood JM, Wolfe SP, Conway SP.

    Pediatr Pulmonol. 2006 Jan;41(1):35-49. Review.PMID: 16288483 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Clinical studies of pediatric malabsorption syndromes]

    Hosoyamada T.

    Fukuoka Igaku Zasshi. 2006 Nov;97(11):322-50. Japanese. PMID: 17228786 [PubMed - indexed for MEDLINE]Related articles

    7.

    Abnormal intracellular lipid processing contributes to fat malabsorption in cystic fibrosis patients.

    Peretti N, Roy CC, Drouin E, Seidman E, Brochu P, Casimir G, Levy E.

    Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G609-15. Epub 2005 Oct 13.PMID: 16223944 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Circulating markers to assess nutritional therapy in cystic fibrosis.

    Wood LG, Gibson PG, Garg ML.

    Clin Chim Acta. 2005 Mar;353(1-2):13-29. Review.PMID: 15698587 [PubMed - indexed for MEDLINE]Related articles

    9.

    Control of malabsorption in cystic fibrosis.

    Littlewood JM, Wolfe SP.

    Paediatr Drugs. 2000 May-Jun;2(3):205-22. Review. Erratum in: Paediatr Drugs 2000 Jul-Aug;2(4):252. PMID: 10937471 [PubMed - indexed for MEDLINE]Related articles

    10.

    Nutrient status of adults with cystic fibrosis.

    Gordon CM, Anderson EJ, Herlyn K, Hubbard JL, Pizzo A, Gelbard R, Lapey A, Merkel PA.

    J Am Diet Assoc. 2007 Dec;107(12):2114-9.PMID: 18060897 [PubMed - indexed for MEDLINE]Related articles

    11.

    Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.

    Jumpsen JA, Brown NE, Thomson AB, Paul Man SF, Goh YK, Ma D, Clandinin MT.

    J Cyst Fibros. 2006 May;5(2):77-84. Epub 2006 Feb 28.PMID: 16507353 [PubMed - indexed for MEDLINE]Related articles

    12.

    Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients.

    Van Biervliet S, Vanbillemont G, Van Biervliet JP, Declercq D, Robberecht E, Christophe A.

    Ann Nutr Metab. 2007;51(6):541-9. Epub 2008 Jan 28.PMID: 18227622 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Nutrition, cystic fibrosis and the digestive tract]

    Olveira G, Olveira C.

    Nutr Hosp. 2008 May;23 Suppl 2:71-86. Review. Spanish. PMID: 18714414 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Directed modification instead of normalization of fatty acid patterns in cystic fibrosis: an emerging concept.

    Christophe A, Robberecht E.

    Curr Opin Clin Nutr Metab Care. 2001 Mar;4(2):111-3. Review.PMID: 11224654 [PubMed - indexed for MEDLINE]Related articles

    15.

    An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis.

    Coste TC, Armand M, Lebacq J, Lebecque P, Wallemacq P, Leal T.

    Clin Biochem. 2007 May;40(8):511-20. Epub 2007 Jan 19. Review.PMID: 17316592 [PubMed - indexed for MEDLINE]Related articles

    16.

    Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic function, Pseudomonas infection, and polyunsaturated fatty acids.

    Keen C, Olin AC, Edentoft A, Gronowitz E, Strandvik B.

    Chest. 2007 Jun;131(6):1857-64. Epub 2007 Mar 30.PMID: 17400678 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    [CFQoL questionnaire as an assessment tool of quality of life in patients with cystic fibrosis]

    Debska G, Mazurek H.

    Pol Merkur Lekarski. 2007 Aug;23(134):137-40. Review. Polish. PMID: 18044346 [PubMed - indexed for MEDLINE]Related articles

    18.

    Serum phospholipid fatty acid pattern is associated with bone mineral density in children, but not adults, with cystic fibrosis.

    Gronowitz E, Mellström D, Strandvik B.

    Br J Nutr. 2006 Jun;95(6):1159-65.PMID: 16768839 [PubMed - indexed for MEDLINE]Related articles

    19.

    Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis.

    Coste TC, Deumer G, Reychler G, Lebecque P, Wallemacq P, Leal T.

    Clin Chem. 2008 Feb;54(2):388-95. Epub 2007 Dec 18.PMID: 18089657 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Decreased coenzyme Q10 concentration in plasma of children with cystic fibrosis.

    Oudshoorn JH, Lecluse AL, van den Berg R, Vaes WH, van der Laag J, Houwen RH.

    J Pediatr Gastroenterol Nutr. 2006 Nov;43(5):646-50.PMID: 17130743 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data